Effect of Combined Spironolactone–β-Blocker ± Enalapril Treatment on Occurrence of Symptomatic Atrial Fibrillation Episodes in Patients With a History of Paroxysmal Atrial Fibrillation (SPIR-AF Study)-Reference-Cited by-同舟云学术

Effect of Combined Spironolactone–β-Blocker ± Enalapril Treatment on Occurrence of Symptomatic Atrial Fibrillation Episodes in Patients With a History of Paroxysmal Atrial Fibrillation (SPIR-AF Study)

Published:2010-12 Issue:11 Volume:106 Page:1609-1614
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Dabrowski Rafal,Borowiec Anna,Smolis-Bak Edyta,Kowalik Ilona,Sosnowski Cezary,Kraska Alicja,Kazimierska Barbara,Wozniak Jacek,Zareba Wojciech,Szwed Hanna

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation;Goette;J Am Coll Cardiol,2000

2. Evidence that angiotensin II enhances noradrenaline releases from sympathetic nerves in mouse atria by activating protein kinase C;Musgrave;J Auton Pharmacol,1991

3. Selective downregulation of the angiotensin II at-1 receptor subtype in failing human ventricular myocardium;Asano;Circulation,1997

4. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data;Black;Am Heart J,2004

5. Aldosterone: cardiovascular assault;Struthers;Am Heart J,2002

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of mineralocorticoid receptor antagonists on new-onset or recurrent atrial fibrillation: a Bayesian and frequentist network meta-analysis of randomized trials;Current Problems in Cardiology;2024-09

2. Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials;European Heart Journal;2024-01-09

3. Incidence and progression of atrial fibrillation in patients with and without heart failure using mineralocorticoid receptor antagonists: a meta-analysis;Clinical Research in Cardiology;2024-01-03

4. Beta-blockers in Hypertensive Left Ventricular Hypertrophy and Atrial Fibrillation Prevention;Current Vascular Pharmacology;2024-01

5. Vascular Endothelial Barrier Protection Prevents Atrial Fibrillation by Preserving Cardiac Nanostructure;JACC: Clinical Electrophysiology;2023-12